DrugPatentWatch Database Preview

PROPRANOLOL HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Propranolol Hydrochloride patents expire, and when can generic versions of Propranolol Hydrochloride launch?

Propranolol Hydrochloride is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Inwood Labs, Mylan, Nortec Dev Assoc, Upsher Smith Labs, Zydus Pharms Usa Inc, Athenex Inc, Baxter Hlthcare Corp, Fosun Pharma, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Morton Grove, West-ward Pharms Int, Ani Pharms Inc, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Northstar Hlthcare, Par Pharm, Purepac Pharm, Roxane, Sandoz, Schering, Superpharm, Teva, Vintage Pharms, Warner Chilcott, Watson Labs, Watson Labs Teva, and Yaopharma Co Ltd. and is included in one hundred and thirty-nine NDAs.

The generic ingredient in PROPRANOLOL HYDROCHLORIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.

Summary for PROPRANOLOL HYDROCHLORIDE

US Patents:	0
Applicants:	38
NDAs:	139
Suppliers / Packagers:	42
Bulk Api Vendors:	102
Clinical Trials:	255
Patent Applications:	3,287
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for PROPRANOLOL HYDROCHLORIDE
DailyMed Link:	PROPRANOLOL HYDROCHLORIDE at DailyMed

Recent Clinical Trials for PROPRANOLOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University Hospital, Bordeaux	Phase 3
AMRO-HHT-France - Association Maladie de Rendu-Osler	Phase 3
Xiangya Hospital of Central South University	Phase 2

See all PROPRANOLOL HYDROCHLORIDE clinical trials

Recent Litigation for PROPRANOLOL HYDROCHLORIDE

Identify potential future generic entrants

District Court Litigation

Case Name	Date
Salix Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.	2017-03-27
Wyeth v. Biovail Corporation	2008-06-26
Plaintiff(s) v. Defendant(s)	2008-01-31

See all PROPRANOLOL HYDROCHLORIDE litigation

Pharmacology for PROPRANOLOL HYDROCHLORIDE

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for PROPRANOLOL HYDROCHLORIDE

Adrenergic beta-Antagonists

Anti-Arrhythmia Agents

Antihypertensive Agents

Vasodilator Agents

Synonyms for PROPRANOLOL HYDROCHLORIDE

( inverted question mark)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride

( inverted question mark)-Propranolol hydrochloride

(??)-Propranolol HCl

(?)-Propranolol hydrochloride

(+-)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride

(+/-)-[2-Hydroxy-3-(naphthyloxy)propyl]isopropylammonium chloride

(+/-)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol, HCl

(+/-)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol hydrochloride

(+/-)-Propranolol hydrochloride

(+/-)-Propranolol hydrochloride, >=99% (TLC), powder

(+/-)-Propranolol hydrochloride, analytical reference material

(+/-)-Propranolol, Hydrochloride

(2-Hydroxy-3-(naphthyloxy)propyl)isopropylammonium chloride

(R)-Propranolol hydrochloride

(RS)-1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol hydrochloride

(y)-Propranolol hydrochloride

1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane hydrochloride

1-(1-Naphthyloxy)-2-hydroxy-3-isopropylaminopropane hydrochloride

1-(1-naphthyloxy)-2-hydroxy-3-isopropylaminopropanehydrochloride

1-(alpha-naphthoxy)-3-(iso-propylamino)-2-propanol hydrochloride

1-(alpha-naphthoxy)-3-(isopropylamino)-2-propanol hydrochloride

1-(Isopropylamino)-3-(.alpha.-naphthoxy)-2-propanol hydrochloride

1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol hydrochloride

1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride

1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol hydrochloride

1-(Isopropylamino)-3-(1-napthyloxy)-2-propanol hydrochloride

1-(Isopropylamino)-3-(alpha-naphthoxy)-2-propanol hydrochloride

1-(Isopropylamino)-3-(naphthalen-1-yloxy)propan-2-ol hydrochloride

1-(naphthalen-1-yloxy)-3-[(propan-2-yl)amino]propan-2-ol hydrochloride

1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol hydrochloride

1-[(methylethyl)amino]-3-naphthyloxypropan-2-ol, chloride

1-Isopropylamino-3-(1-naphthoxy)-propan-2-ol-hydrochloride

1-Isopropylamino-3-(1-naphthyloxy)-2-propanol hydrochloride

1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol hydrochloride

1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride

146874-86-4

2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydrochloride

2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydrochloride, (+-)-

2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, hydrochloride

2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, hydrochloride, (+-)-

3-[(methylethyl)amino]-1-naphthyloxypropan-2-ol, chloride

318-98-9

3506-09-0

4289AB

AB0011639

AC1L1XZ4

Acifol

ACM318989

ACT02695

AKOS005267141

AN-23392

Anaprilin

Anapriline

Angilol

ANW-62232

Apsolol

Arcablock

ARONIS24408

Artensol

Avlocardyl

AX8233861

AY 64043

AY-64043

BBC/572

BCP15350

Beprane

Berkolol

Beta Neg

beta-NEG

Beta-Tablinen

Beta-Timelets

BG0302

BIM-0050871.0001

Biocard

Blocaryl

C-4618

C16H21NO2.HCl

C16H22ClNO2

Cardinol

Caridolol

CAS-318-98-9

CC-33976

CCG-39239

CCG-39447

CCRIS 1105

CHEBI:8500

CHEMBL1671

CHM0004159

Cinlol

Ciplar

Corbeta

CPD000059167

CS-2680

CTK3J2636

d,l-Propranolol hydrochloride

D00483

Deralin

Detensol

Dibudinate

DL-Anapriline

DL-Propranolol hydrochloride

DL-Propranolol hydrochloride, 99%

Dociton

DSSTox_CID_1198

DSSTox_GSID_21198

DSSTox_RID_76007

DTXSID3021198

Dumopranol

Duranol

Efectolol

Efektolol

EINECS 206-268-7

EINECS 222-501-5

Elbrol

Emforal

EU-0100896

EUR-1000

Farprolol

Frekven

FT-0603377

FT-0635178

GP3553

Half-Inderal

Hemangeol

Hemipralon

Herzbase

Herzul

HMS1570P06

HMS1571G12

HMS1571I04

HMS1922P19

HSDB 3176

HY-B0573

I 2065

I14-2718

ICI 45520

ICI-45520

Ikopal

IN1139

Inderal

Inderal (TN)

Inderal hydrochloride

Inderal La

Inderalici

Inderex

Indermigran

Inderol

Indobloc

Innopran

InnoPran XL

Innopran XL (TN)

J10004

Jsp005924

KB-215769

KDM-1102

Kemi

Kidoral

KS-00000V0D

KS-1097

LP00896

LS-7676

MCULE-6124856976

MFCD00012558

Migrastat

MLS000859628

MLS001055449

MLS001056753

MLS002222321

MLS002548855

MolPort-001-759-087

Naprilin

NC00687

NCGC00024690-04

NCGC00091932-01

NCGC00094212-01

NCGC00094212-02

NCGC00094212-03

NCGC00094212-04

NCGC00094212-05

NCGC00256554-01

NCGC00259435-01

NCGC00261581-01

Nedis

Nelderal

Noloten

Novopranol

NSC 91523

NSC-758950

NSC-91523

NSC758950

NSC91523

Obsidan

Oposim

P 0884

P0995

Panolol

Pharmakon1600-01505270

Prandol

Pranix

Prano-Puren

Pranolol

Proberta LA

Procor

Pronovan

Propabloc

Propadex

Propalong

Propanolol hydrochloride

Propayerst

Prophylux

propra vt ct

Proprahexal

Propral

propranolol (hydrochloride)

Propranolol chloride

Propranolol Hcl

Propranolol Hcl Intensol

PROPRANOLOL HYDROCHLORIDE (+/-)

Propranolol hydrochloride (JP17/USP)

Propranolol hydrochloride [USAN:JAN]

Propranolol hydrochloride [USAN:USP:JAN]

Propranolol Hydrochloride 1.0 mg/ml in Methanol (as free base)

Propranolol hydrochloride for performance test, European Pharmacopoeia (EP) Reference Standard

Propranolol hydrochloride intensol

Propranolol hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material

Propranolol hydrochloride, 99%

Propranolol hydrochloride, European Pharmacopoeia (EP) Reference Standard

Propranolol hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

Propranolol hydrochloride, United States Pharmacopeia (USP) Reference Standard

Propranolol.HCl

PROPRANOLOLHYDROCHLORIDE

Propranolon hydrochloride

Propranovitan

Propranur

Propraratiopharm

Prosin

Pur-Bloka

Pylapron

Q-201632

R+C5989educor

Rapynogen

Relax-B

RTR-013480

s4076

Sagittol

SAM002264638

SAM002699889

Sawatol

SBB080817

SC-15116

Scandrug

SCHEMBL41688

Sinal

Sloprolol

SMR000059167

SPECTRUM1505270

SR-01000075285

SR-01000075285-1

SR-01000075285-3

ST50319806

Sudenol

SW219414-1

Tensiflex

Tesnol

Tev-Tropin

Tiperal

TL8002432

Tonum

Tox21_201886

Tox21_302905

Tox21_500896

TR-013480

W-109142

WLN: L66J BO1YQ1MY1 & 1 & GH

Z90121066

ZMRUPTIKESYGQW-UHFFFAOYSA-N

ZX-AS004773

Paragraph IV (Patent) Challenges for PROPRANOLOL HYDROCHLORIDE

Tradename	Dosage	Ingredient	NDA	Submissiondate
INDERAL LA	CAPSULE, EXTENDED RELEASE;ORAL	propranolol hydrochloride	018553

US Patents and Regulatory Information for PROPRANOLOL HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ipca Labs Ltd	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	078955-004	Jun 2, 2008	AB	RX	No	No
Roxane	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	070517-001	Jul 7, 1986		DISCN	No	No
Ani Pharms Inc	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	071791-001	Jul 15, 1987		DISCN	No	No
Fresenius Kabi Usa	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	INJECTABLE;INJECTION	075826-001	Aug 31, 2001	AP	RX	No	No
Ani Pharms Inc	PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; propranolol hydrochloride	TABLET;ORAL	070705-001	Oct 1, 1986		DISCN	No	No